| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 5,139.3 | 2,986.0 |
| Profit before tax | 175.4 | -139.3 |
| Net income | 167.3 | -137.4 |
| EPS (diluted, $ a share) | $0.49 | $-0.53 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +72.1% |
|---|---|
| Operating margin | 3.5% |
10-Q filed with the SEC, NYSE: OSCR. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Oscar Health, Inc.: key numbers
- Share price
- $31.33Close, Nov 16
- Sector
- Finance
- Industry
- Hospital & Medical Service PlansSIC 6324
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Oscar Health, Inc.
All →Oscar Health Leadership Change
Oscar Health appointed Tomer Cohen, Eric Larsen, and Rajat Taneja to its Board of Directors, effective November 13, 2026, increasing the board size from eight to eleven. The new directors bring expertise from LinkedIn, Visa, and healthcare advisory roles, with specific appointments to the Audit, Compensation, and Nominating committees. All three appointees were determined to be independent under NYSE rules.
Oscar Health Earnings Call: Key Takeaways
Oscar Health delivered a significant beat and raise, driven by disciplined pricing, favorable risk adjustment data, and AI-powered administrative efficiency, positioning the company for sustainable profitability and a $4 EPS target by 2029.
- Call
- Nov 5, 2026, 8:00 AM ET
Oscar Health Financial Results
Oscar Health reported Q3 2026 financial results with total revenue of $5.14 billion, a significant increase from $2.99 billion in the prior year. The company achieved net income of $167.3 million compared to a net loss in Q3 2025 and raised its full-year 2026 earnings from operations outlook to a range of $850 million to $950 million.
- Term
- Q3 2026
“Oscar Health is on track to deliver the strongest year of financial performance in our history, and we are raising our earnings from operations outlook for a third time. The ACA is the foundation of a rapidly-developing individual market in America, and Oscar Health is built to lead it. Our disciplined pricing, consumer-led products, and technology-powered approach are driving stronger economics and position us to grow market share and expand margin in 2027.”
Mark Bertolini, CEO of Oscar Health
Oscar Health Investor Presentation
Oscar Health is hosting its 2026 Investor Day to discuss its long-term strategy and financial targets. During the event, the company raised its full-year 2026 guidance for Earnings from Operations to a range of $600 million to $800 million and improved its Medical Loss Ratio outlook.
- Earnings call
- Sep 16, 2026, 9:00 AM ET